Deferoxamine mesylate
Deferoxamine Mesylate for Injection, USPVialsRx onlyPrescribing Information
Approved
Approval ID
c99553fb-3fae-b88a-6c2c-efa7520197f9
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Dec 1, 2023
Manufacturers
FDA
Apotex Corp.
DUNS: 845263701
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Deferoxamine mesylate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code60505-6237
Application NumberANDA207384
Product Classification
M
Marketing Category
C73584
G
Generic Name
Deferoxamine mesylate
Product Specifications
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS
Effective DateDecember 1, 2023
FDA Product Classification
INGREDIENTS (1)
DEFEROXAMINE MESYLATEActive
Quantity: 2 g in 1 1
Code: V9TKO7EO6K
Classification: ACTIB
Deferoxamine mesylate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code60505-6236
Application NumberANDA207384
Product Classification
M
Marketing Category
C73584
G
Generic Name
Deferoxamine mesylate
Product Specifications
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
Effective DateDecember 1, 2023
FDA Product Classification
INGREDIENTS (1)
DEFEROXAMINE MESYLATEActive
Quantity: 500 mg in 1 1
Code: V9TKO7EO6K
Classification: ACTIB